人类和细菌粉样蛋白之间的分子相互作用:神经退行性疾病的影响
1Department of Bioscience and Bioengineering, Indian Institute of Technology Jodhpur, NH 62, Surpura Bypass, Karwar, 342030, Rajasthan, India.
Biochimica et biophysica acta. Proteins and proteomics
|April 19, 2024
概括
细菌粉样蛋白可能会影响人类的粉样蛋白疾病,如阿尔茨海默病和帕金森病. 这篇评论探讨了肠-大脑轴连接和细菌粉样蛋白在神经退行症中的作用.
科学领域:
- 神经生物学 神经生物学 神经生物学
- 微生物学 微生物学
- 生物化学 生化学
背景情况:
- 神经退行性疾病,包括帕金森氏症 (PD) 和阿尔茨海默氏症 (AD),与蛋白质粉样蛋白形成有关.
- 研究主要集中在内源性粉样蛋白,但细菌粉样蛋白越来越多地受到影响.
研究的目的:
- 审查细菌粉样蛋白在人类神经退行性疾病中的新兴作用.
- 探索细菌粉样蛋白影响肠-大脑轴并影响AD和PD进展的潜在机制.
主要方法:
- 对细菌粉样蛋白和神经退行症研究的文献综述.
- 对肠-大脑轴作为通讯通道的分析.
- 检查将细菌和人类氨基代结合在一起的分子机制.
主要成果:
- 越来越多的证据表明,细菌粉样蛋白可以调节人类粉样蛋白的形成.
- 肠-大脑轴为细菌对神经健康的影响提供了潜在的途径.
- 细菌粉样蛋白可能会加剧或导致PD和AD的发病.
结论:
- 细菌粉样蛋白代表了神经退行性疾病的发展和进展的一个新型因素.
- 向细菌粉样蛋白或肠-大脑轴可能为AD和PD提供新的治疗策略.
- 需要进一步的研究,以充分阐明微生物和人类粉样蛋白之间的复杂相互作用.
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Alzheimer's Disease: Overview
468
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
468


